SUFFERN, N.Y., Feb. 13 (UPI) -- Ferring said Monday a study shows its arthritis drug Euflexxa works better and is more tolerable than Genzyme's Synvisc. "This study shows that Euflexxa offers better ...
The FDA has approved a labeling supplement for Euflexxa (sodium hyaluronate intra-articular injection; Ferring) to include 26-week efficacy data from the FLEXX trial, as well as, 52-week safety data ...
Results of FLEXX Trial Presented at the Osteoarthritis Research Society International's 2008 World Congress PARSIPPANY, N.J., Oct. 7 /PRNewswire/ -- Ferring Pharmaceuticals Inc. recently presented ...
Sports sponsorships and awareness campaigns aimed at seniors are staples of pharmaceutical communications. Ferring Pharmaceuticals has found a way to combine them with a multi-year sponsorship of the ...
PARSIPPANY, N.J., April 18 Ferring Pharmaceuticals Inc.has announced that its hyaluronic acid (HA) therapy, EUFLEXXA(TM) (1% sodiumhyaluronate), will serve as the sponsor for masters track club Sprint ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results